Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.69 BRL | +1.30% | +7.74% | +0.60% |
Feb. 29 | Transcript : Odontoprev S.A., Q4 2023 Earnings Call, Feb 29, 2024 | |
Feb. 28 | Odontoprev S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2024 * | 2.3B 450M | Sales 2025 * | 2.46B 482M | Capitalization | 6.46B 1.26B |
---|---|---|---|---|---|
Net income 2024 * | 528M 103M | Net income 2025 * | 547M 107M | EV / Sales 2024 * | 2.48 x |
Net cash position 2024 * | 740M 145M | Net cash position 2025 * | 607M 119M | EV / Sales 2025 * | 2.38 x |
P/E ratio 2024 * |
11.9
x | P/E ratio 2025 * |
11.6
x | Employees | 1,947 |
Yield 2024 * |
7.08% | Yield 2025 * |
7.57% | Free-Float | 47.11% |
Latest transcript on Odontoprev S.A.
1 day | +1.30% | ||
1 week | +7.74% | ||
Current month | -3.87% | ||
1 month | -2.83% | ||
3 months | -3.47% | ||
6 months | +12.51% | ||
Current year | +0.60% |
Managers | Title | Age | Since |
---|---|---|---|
Rodrigo Bacellar
CEO | Chief Executive Officer | 57 | 16-05-31 |
Director of Finance/CFO | - | 05-12-31 | |
Rose Gabay
HRO | Human Resources Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 72 | 19-05-02 | |
Director/Board Member | 78 | 06-12-31 | |
Director/Board Member | 76 | 08-03-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.39% | 2 M€ | -14.14% | ||
0.01% | 4 M€ | -4.41% | - | |
0.00% | 117 M€ | +1.11% | - | |
0.00% | 34 M€ | +2.14% | - | |
0.00% | 34 M€ | +4.85% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 11.54 | +4.43% | 1,087,900 |
24-04-24 | 11.05 | +1.10% | 1,612,000 |
24-04-23 | 10.93 | +0.74% | 2,587,000 |
24-04-22 | 10.85 | 0.00% | 1,635,800 |
24-04-19 | 10.85 | +0.18% | 1,877,300 |
Delayed Quote Sao Paulo, April 26, 2024 at 04:07 pm EDT
More quotesEPS Revisions
- Stock Market
- Equities
- ODPV3 Stock